Friday, July 10, 2026

pharma · Bowel Preparation

Second Affiliated Hospital

Second Affiliated Hospital drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
1
Drugs
1
Patents
0
Intelligence · Drug Pipeline

Second Affiliated Hospital pipeline

Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Second Affiliated Hospital drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

1 compounds
  1. linaclotide

    Alimentary tract and metabolism (A06)

    US regulatory status: approved. Molecular target: Guanylyl cyclase C.

    Target
    Guanylyl cyclase C
    Mechanism
    Heat-stable enterotoxin receptor agonist